25 XP   0   0   10

VISTA PHARMACEUTICALS LTD.
Buy, Hold or Sell?

Let's analyse VISTA PHARMACEUTICALS LTD. together

PenkeI guess you are interested in VISTA PHARMACEUTICALS LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of VISTA PHARMACEUTICALS LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about VISTA PHARMACEUTICALS LTD.

I send you an email if I find something interesting about VISTA PHARMACEUTICALS LTD..

Quick analysis of VISTA PHARMACEUTICALS LTD. (30 sec.)










What can you expect buying and holding a share of VISTA PHARMACEUTICALS LTD.? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
INR9.77
Expected worth in 1 year
INR10.33
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
INR0.55
Return On Investment
4.1%

For what price can you sell your share?

Current Price per Share
INR13.50
Expected price per share
INR10.50 - INR16.06
How sure are you?
50%

1. Valuation of VISTA PHARMACEUTICALS LTD. (5 min.)




Live pricePrice per Share (EOD)

INR13.50

Intrinsic Value Per Share

INR-14.01 - INR23.44

Total Value Per Share

INR-4.23 - INR33.21

2. Growth of VISTA PHARMACEUTICALS LTD. (5 min.)




Is VISTA PHARMACEUTICALS LTD. growing?

Current yearPrevious yearGrowGrow %
How rich?$4.4m$4.2m$150.5k3.4%

How much money is VISTA PHARMACEUTICALS LTD. making?

Current yearPrevious yearGrowGrow %
Making money-$679.4k-$106.6k-$572.8k-84.3%
Net Profit Margin-564.1%-225.2%--

How much money comes from the company's main activities?

3. Financial Health of VISTA PHARMACEUTICALS LTD. (5 min.)




What can you expect buying and holding a share of VISTA PHARMACEUTICALS LTD.? (5 min.)

Welcome investor! VISTA PHARMACEUTICALS LTD.'s management wants to use your money to grow the business. In return you get a share of VISTA PHARMACEUTICALS LTD..

What can you expect buying and holding a share of VISTA PHARMACEUTICALS LTD.?

First you should know what it really means to hold a share of VISTA PHARMACEUTICALS LTD.. And how you can make/lose money.

Speculation

The Price per Share of VISTA PHARMACEUTICALS LTD. is INR13.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of VISTA PHARMACEUTICALS LTD..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in VISTA PHARMACEUTICALS LTD., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR9.77. Based on the TTM, the Book Value Change Per Share is INR0.14 per quarter. Based on the YOY, the Book Value Change Per Share is INR0.71 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of VISTA PHARMACEUTICALS LTD..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps-0.02-0.1%-0.02-0.1%0.000.0%-0.01-0.1%0.000.0%
Usd Book Value Change Per Share0.000.0%0.000.0%0.010.1%0.000.0%0.010.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.000.0%0.010.1%0.000.0%0.010.1%
Usd Price Per Share0.10-0.10-0.11-0.12-0.19-
Price to Earnings Ratio-5.55--5.55--38.18-2.35-32.13-
Price-to-Total Gains Ratio60.39-60.39-13.01-19.81-27.71-
Price to Book Ratio0.86-0.86-0.96-1.10-3.01-
Price-to-Total Gains Ratio60.39-60.39-13.01-19.81-27.71-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.162
Number of shares6172
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (6172 shares)10.2516.53
Gains per Year (6172 shares)41.0166.10
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10413106656
2082720132122
301231130198188
401641540264254
502051950331320
602462360397386
702872770463452
803283180529518
903693590595584
1004104000661650

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%6.04.00.060.0%7.04.00.063.6%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%10.01.00.090.9%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.011.00.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%9.01.00.090.0%10.01.00.090.9%

Fundamentals of VISTA PHARMACEUTICALS LTD.

About VISTA PHARMACEUTICALS LTD.

Vista Pharmaceuticals Limited manufactures and sells pharmaceutical, medical, and veterinary preparations in India, the United States, and internationally. It offers over the counter and prescription generic drugs consisting of tablets, capsules, and liquids covering various therapeutic categories. Vista Pharmaceuticals Limited was incorporated in 1991 and is based in Hyderabad, India.

Fundamental data was last updated by Penke on 2024-04-04 08:11:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of VISTA PHARMACEUTICALS LTD..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit VISTA PHARMACEUTICALS LTD. earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare VISTA PHARMACEUTICALS LTD. to the  Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -564.1% means that ₹-5.64 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of VISTA PHARMACEUTICALS LTD.:

  • The MRQ is -564.1%. The company is making a huge loss. -2
  • The TTM is -564.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-564.1%TTM-564.1%0.0%
TTM-564.1%YOY-225.2%-338.9%
TTM-564.1%5Y-192.2%-371.9%
5Y-192.2%10Y-92.8%-99.4%
1.1.2. Return on Assets

Shows how efficient VISTA PHARMACEUTICALS LTD. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare VISTA PHARMACEUTICALS LTD. to the  Drug Manufacturers - Specialty & Generic industry mean.
  • -10.1% Return on Assets means that VISTA PHARMACEUTICALS LTD. generated ₹-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of VISTA PHARMACEUTICALS LTD.:

  • The MRQ is -10.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-10.1%TTM-10.1%0.0%
TTM-10.1%YOY-1.6%-8.5%
TTM-10.1%5Y-4.2%-5.9%
5Y-4.2%10Y-0.2%-4.0%
1.1.3. Return on Equity

Shows how efficient VISTA PHARMACEUTICALS LTD. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare VISTA PHARMACEUTICALS LTD. to the  Drug Manufacturers - Specialty & Generic industry mean.
  • -15.4% Return on Equity means VISTA PHARMACEUTICALS LTD. generated ₹-0.15 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of VISTA PHARMACEUTICALS LTD.:

  • The MRQ is -15.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -15.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.4%TTM-15.4%0.0%
TTM-15.4%YOY-2.5%-12.9%
TTM-15.4%5Y-6.8%-8.7%
5Y-6.8%10Y0.5%-7.3%

1.2. Operating Efficiency of VISTA PHARMACEUTICALS LTD..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient VISTA PHARMACEUTICALS LTD. is operating .

  • Measures how much profit VISTA PHARMACEUTICALS LTD. makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare VISTA PHARMACEUTICALS LTD. to the  Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of VISTA PHARMACEUTICALS LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-4.5%+4.5%
5Y-4.5%10Y4.0%-8.5%
1.2.2. Operating Ratio

Measures how efficient VISTA PHARMACEUTICALS LTD. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 8.05 means that the operating costs are ₹8.05 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of VISTA PHARMACEUTICALS LTD.:

  • The MRQ is 8.049. The company is inefficient in keeping operating costs low. -1
  • The TTM is 8.049. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ8.049TTM8.0490.000
TTM8.049YOY7.178+0.871
TTM8.0495Y4.581+3.468
5Y4.58110Y3.063+1.518

1.3. Liquidity of VISTA PHARMACEUTICALS LTD..

1.3. Liquidity
1.3.1. Current Ratio

Measures if VISTA PHARMACEUTICALS LTD. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.69 means the company has ₹1.69 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of VISTA PHARMACEUTICALS LTD.:

  • The MRQ is 1.687. The company is able to pay all its short-term debts. +1
  • The TTM is 1.687. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.687TTM1.6870.000
TTM1.687YOY1.864-0.178
TTM1.6875Y1.734-0.048
5Y1.73410Y1.558+0.177
1.3.2. Quick Ratio

Measures if VISTA PHARMACEUTICALS LTD. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare VISTA PHARMACEUTICALS LTD. to the  Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.80 means the company can pay off ₹0.80 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of VISTA PHARMACEUTICALS LTD.:

  • The MRQ is 0.799. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.799. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.799TTM0.7990.000
TTM0.799YOY0.828-0.029
TTM0.7995Y0.675+0.123
5Y0.67510Y0.744-0.069

1.4. Solvency of VISTA PHARMACEUTICALS LTD..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of VISTA PHARMACEUTICALS LTD. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare VISTA PHARMACEUTICALS LTD. to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.34 means that VISTA PHARMACEUTICALS LTD. assets are financed with 34.5% credit (debt) and the remaining percentage (100% - 34.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of VISTA PHARMACEUTICALS LTD.:

  • The MRQ is 0.345. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.345. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.345TTM0.3450.000
TTM0.345YOY0.362-0.017
TTM0.3455Y0.361-0.016
5Y0.36110Y0.428-0.067
1.4.2. Debt to Equity Ratio

Measures if VISTA PHARMACEUTICALS LTD. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare VISTA PHARMACEUTICALS LTD. to the  Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 52.6% means that company has ₹0.53 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of VISTA PHARMACEUTICALS LTD.:

  • The MRQ is 0.526. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.526. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.526TTM0.5260.000
TTM0.526YOY0.568-0.042
TTM0.5265Y0.568-0.042
5Y0.56810Y0.814-0.246

2. Market Valuation of VISTA PHARMACEUTICALS LTD.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings VISTA PHARMACEUTICALS LTD. generates.

  • Above 15 is considered overpriced but always compare VISTA PHARMACEUTICALS LTD. to the  Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -5.55 means the investor is paying ₹-5.55 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of VISTA PHARMACEUTICALS LTD.:

  • The EOD is -8.955. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.545. Based on the earnings, the company is expensive. -2
  • The TTM is -5.545. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.955MRQ-5.545-3.409
MRQ-5.545TTM-5.5450.000
TTM-5.545YOY-38.177+32.632
TTM-5.5455Y2.354-7.900
5Y2.35410Y32.132-29.777
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of VISTA PHARMACEUTICALS LTD.:

  • The EOD is -17.004. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.530. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.530. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-17.004MRQ-10.530-6.474
MRQ-10.530TTM-10.5300.000
TTM-10.530YOY-33.678+23.148
TTM-10.5305Y-20.189+9.659
5Y-20.18910Y-79.684+59.495
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of VISTA PHARMACEUTICALS LTD. is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of VISTA PHARMACEUTICALS LTD.:

  • The EOD is 1.381. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.855. Based on the equity, the company is cheap. +2
  • The TTM is 0.855. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.381MRQ0.855+0.526
MRQ0.855TTM0.8550.000
TTM0.855YOY0.957-0.102
TTM0.8555Y1.103-0.247
5Y1.10310Y3.015-1.912
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of VISTA PHARMACEUTICALS LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1380.1380%0.709-80%0.223-38%0.744-81%
Book Value Per Share--9.7749.7740%9.636+1%9.225+6%6.752+45%
Current Ratio--1.6871.6870%1.864-10%1.734-3%1.558+8%
Debt To Asset Ratio--0.3450.3450%0.362-5%0.361-4%0.428-19%
Debt To Equity Ratio--0.5260.5260%0.568-7%0.568-7%0.814-35%
Dividend Per Share----0%-0%-0%-0%
Eps---1.508-1.5080%-0.242-84%-0.608-60%-0.140-91%
Free Cash Flow Per Share---0.794-0.7940%-0.274-66%-0.775-2%-0.984+24%
Free Cash Flow To Equity Per Share---0.794-0.7940%-0.274-66%-0.697-12%-0.286-64%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--23.436--------
Intrinsic Value_10Y_min---14.009--------
Intrinsic Value_1Y_max---0.101--------
Intrinsic Value_1Y_min---1.109--------
Intrinsic Value_3Y_max--1.562--------
Intrinsic Value_3Y_min---3.606--------
Intrinsic Value_5Y_max--5.477--------
Intrinsic Value_5Y_min---6.387--------
Market Cap496717650.000+37%313973502.040313973502.0400%339239822.540-7%381503487.772-18%586654107.886-46%
Net Profit Margin---5.641-5.6410%-2.252-60%-1.922-66%-0.928-84%
Operating Margin----0%-0%-0.0450%0.040-100%
Operating Ratio--8.0498.0490%7.178+12%4.581+76%3.063+163%
Pb Ratio1.381+38%0.8550.8550%0.957-11%1.103-22%3.015-72%
Pe Ratio-8.955-61%-5.545-5.5450%-38.177+588%2.354-336%32.132-117%
Price Per Share13.500+38%8.3608.3600%9.220-9%10.334-19%15.927-48%
Price To Free Cash Flow Ratio-17.004-61%-10.530-10.5300%-33.678+220%-20.189+92%-79.684+657%
Price To Total Gains Ratio97.528+38%60.39560.3950%13.013+364%19.810+205%27.708+118%
Quick Ratio--0.7990.7990%0.828-3%0.675+18%0.744+7%
Return On Assets---0.101-0.1010%-0.016-84%-0.042-58%-0.002-98%
Return On Equity---0.154-0.1540%-0.025-84%-0.068-56%0.005-3035%
Total Gains Per Share--0.1380.1380%0.709-80%0.223-38%0.744-81%
Usd Book Value--4404924.0004404924.0000%4254348.000+4%4090783.200+8%2990249.140+47%
Usd Book Value Change Per Share--0.0020.0020%0.009-80%0.003-38%0.009-81%
Usd Book Value Per Share--0.1170.1170%0.116+1%0.111+6%0.081+45%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.018-0.0180%-0.003-84%-0.007-60%-0.002-91%
Usd Free Cash Flow---357804.000-357804.0000%-120876.000-66%-343447.200-4%-435390.186+22%
Usd Free Cash Flow Per Share---0.010-0.0100%-0.003-66%-0.009-2%-0.012+24%
Usd Free Cash Flow To Equity Per Share---0.010-0.0100%-0.003-66%-0.008-12%-0.003-64%
Usd Market Cap5960611.800+37%3767682.0243767682.0240%4070877.870-7%4578041.853-18%7039849.295-46%
Usd Price Per Share0.162+38%0.1000.1000%0.111-9%0.124-19%0.191-48%
Usd Profit---679440.000-679440.0000%-106632.000-84%-271130.400-60%-64280.196-91%
Usd Revenue--120444.000120444.0000%47352.000+154%1355916.000-91%1764506.832-93%
Usd Total Gains Per Share--0.0020.0020%0.009-80%0.003-38%0.009-81%
 EOD+6 -2MRQTTM+0 -0YOY+9 -235Y+10 -2210Y+14 -19

3.2. Fundamental Score

Let's check the fundamental score of VISTA PHARMACEUTICALS LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.955
Price to Book Ratio (EOD)Between0-11.381
Net Profit Margin (MRQ)Greater than0-5.641
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.799
Current Ratio (MRQ)Greater than11.687
Debt to Asset Ratio (MRQ)Less than10.345
Debt to Equity Ratio (MRQ)Less than10.526
Return on Equity (MRQ)Greater than0.15-0.154
Return on Assets (MRQ)Greater than0.05-0.101
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of VISTA PHARMACEUTICALS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.031
Ma 20Greater thanMa 5012.563
Ma 50Greater thanMa 10013.824
Ma 100Greater thanMa 20015.099
OpenGreater thanClose13.320
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets560,294
Total Liabilities193,217
Total Stockholder Equity367,077
 As reported
Total Liabilities 193,217
Total Stockholder Equity+ 367,077
Total Assets = 560,294

Assets

Total Assets560,294
Total Current Assets237,506
Long-term Assets322,789
Total Current Assets
Cash And Cash Equivalents 1,429
Net Receivables 112,509
Inventory 76,768
Other Current Assets 52,936
Total Current Assets  (as reported)237,506
Total Current Assets  (calculated)243,642
+/- 6,136
Long-term Assets
Property Plant Equipment 195,141
Intangible Assets 95,530
Long-term Assets  (as reported)322,789
Long-term Assets  (calculated)290,671
+/- 32,118

Liabilities & Shareholders' Equity

Total Current Liabilities140,823
Long-term Liabilities52,394
Total Stockholder Equity367,077
Total Current Liabilities
Short Long Term Debt 47,797
Accounts payable 78,026
Other Current Liabilities 18,890
Total Current Liabilities  (as reported)140,823
Total Current Liabilities  (calculated)144,713
+/- 3,890
Long-term Liabilities
Long term Debt 51,793
Long-term Liabilities Other -1
Long-term Liabilities  (as reported)52,394
Long-term Liabilities  (calculated)51,792
+/- 602
Total Stockholder Equity
Total Stockholder Equity (as reported)367,077
Total Stockholder Equity (calculated)0
+/- 367,077
Other
Capital Stock75,113
Common Stock Shares Outstanding 37,557
Net Debt 98,161
Net Invested Capital 466,667
Net Working Capital 96,683
Property Plant and Equipment Gross 265,366



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-31
> Total Assets 
144,000
140,600
227,780
263,802
412,500
530,015
527,578
511,217
508,535
555,898
560,294
560,294555,898508,535511,217527,578530,015412,500263,802227,780140,600144,000
   > Total Current Assets 
19,000
22,915
119,733
163,420
255,023
278,382
234,469
211,851
152,365
235,625
237,506
237,506235,625152,365211,851234,469278,382255,023163,420119,73322,91519,000
       Cash And Cash Equivalents 
2,000
960
970
4,322
57,403
10,290
1,148
1,643
791
109
1,429
1,4291097911,6431,14810,29057,4034,3229709602,000
       Net Receivables 
4,000
14,743
115,654
102,205
98,812
132,439
95,272
102,804
21,692
104,640
112,509
112,509104,64021,692102,80495,272132,43998,812102,205115,65414,7434,000
       Inventory 
13,000
6,936
2,217
26,760
81,427
109,123
112,459
96,815
96,815
93,275
76,768
76,76893,27596,81596,815112,459109,12381,42726,7602,2176,93613,000
   > Long-term Assets 
0
0
0
0
119,353
251,633
293,109
299,366
356,170
320,273
322,789
322,789320,273356,170299,366293,109251,633119,3530000
       Property Plant Equipment 
0
116,919
107,282
99,616
117,535
190,409
209,926
196,358
194,615
188,613
195,141
195,141188,613194,615196,358209,926190,409117,53599,616107,282116,9190
       Long Term Investments 
0
5
5
5
5
198
293
0
0
0
0
000029319855550
       Intangible Assets 
0
0
0
0
0
57,365
80,717
95,530
95,530
95,530
95,530
95,53095,53095,53095,53080,71757,36500000
       Other Assets 
0
761
761
761
43,660
61,026
82,890
4,762
0
0
0
0004,76282,89061,02643,6607617617610
> Total Liabilities 
58,000
49,653
123,422
151,702
251,097
211,441
169,571
214,797
180,075
201,369
193,217
193,217201,369180,075214,797169,571211,441251,097151,702123,42249,65358,000
   > Total Current Liabilities 
56,000
47,027
121,935
72,380
189,313
151,988
109,470
159,218
92,459
126,393
140,823
140,823126,39392,459159,218109,470151,988189,31372,380121,93547,02756,000
       Short-term Debt 
0
0
40,372
78,776
53,080
51,803
52,097
0
0
0
0
000052,09751,80353,08078,77640,37200
       Short Long Term Debt 
0
0
40,372
78,776
53,080
51,803
52,098
99,607
20,191
51,252
47,797
47,79751,25220,19199,60752,09851,80353,08078,77640,37200
       Accounts payable 
30,000
43,194
77,470
65,491
129,314
91,276
52,534
51,615
51,050
53,666
78,026
78,02653,66651,05051,61552,53491,276129,31465,49177,47043,19430,000
       Other Current Liabilities 
20,000
629
1,176
3,437
3,784
2,494
1,494
5,634
18,297
-1
18,890
18,890-118,2975,6341,4942,4943,7843,4371,17662920,000
   > Long-term Liabilities 
0
0
0
0
61,747
59,453
60,101
55,579
87,616
74,976
52,394
52,39474,97687,61655,57960,10159,45361,7470000
       Other Liabilities 
0
2,625
1,487
546
522
609
547
514
0
0
0
0005145476095225461,4872,6250
       Deferred Long Term Liability 
0
0
0
0
36,966
57,365
80,717
0
0
0
0
000080,71757,36536,9660000
> Total Stockholder Equity
0
90,947
104,358
112,100
161,403
318,574
358,007
296,420
328,460
354,529
367,077
367,077354,529328,460296,420358,007318,574161,403112,100104,35890,9470
   Common Stock
186,000
150,000
50,000
50,000
53,143
58,294
60,731
60,731
0
0
0
00060,73160,73158,29453,14350,00050,000150,000186,000
   Retained Earnings 
-109,000
-104,518
8,893
16,635
34,336
56,202
65,596
27,323
-30,638
-4,468
-61,088
-61,088-4,468-30,63827,32365,59656,20234,33616,6358,893-104,518-109,000
   Capital Surplus 00000000000
   Treasury Stock00000000000
   Other Stockholders Equity 
0
9,595
9,595
9,595
8,095
63,788
32,919
235,689
0
0
0
000235,68932,91963,7888,0959,5959,5959,5950



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue10,037
Cost of Revenue-31,942
Gross Profit-21,905-21,905
 
Operating Income (+$)
Gross Profit-21,905
Operating Expense-48,846
Operating Income-38,809-70,751
 
Operating Expense (+$)
Research Development0
Selling General Administrative2,017
Selling And Marketing Expenses0
Operating Expense48,8462,017
 
Net Interest Income (+$)
Interest Income1,293
Interest Expense-13,099
Other Finance Cost-314
Net Interest Income-12,120
 
Pretax Income (+$)
Operating Income-38,809
Net Interest Income-12,120
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-58,763-38,809
EBIT - interestExpense = -13,099
-56,620
-43,521
Interest Expense13,099
Earnings Before Interest and Taxes (EBIT)0-45,664
Earnings Before Interest and Taxes (EBITDA)-19,358
 
After tax Income (+$)
Income Before Tax-58,763
Tax Provision--2,143
Net Income From Continuing Ops-56,620-56,620
Net Income-56,620
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net012,120
 

Technical Analysis of VISTA PHARMACEUTICALS LTD.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of VISTA PHARMACEUTICALS LTD.. The general trend of VISTA PHARMACEUTICALS LTD. is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine VISTA PHARMACEUTICALS LTD.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of VISTA PHARMACEUTICALS LTD..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 14.45 < 14.50 < 16.06.

The bearish price targets are: 11.00 > 10.50 > 10.50.

Tweet this
VISTA PHARMACEUTICALS LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of VISTA PHARMACEUTICALS LTD.. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

VISTA PHARMACEUTICALS LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of VISTA PHARMACEUTICALS LTD.. The current macd is -0.03942724.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the VISTA PHARMACEUTICALS LTD. price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for VISTA PHARMACEUTICALS LTD.. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the VISTA PHARMACEUTICALS LTD. price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
VISTA PHARMACEUTICALS LTD. Daily Moving Average Convergence/Divergence (MACD) ChartVISTA PHARMACEUTICALS LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of VISTA PHARMACEUTICALS LTD.. The current adx is 24.27.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy VISTA PHARMACEUTICALS LTD. shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
VISTA PHARMACEUTICALS LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of VISTA PHARMACEUTICALS LTD.. The current sar is 12.35.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
VISTA PHARMACEUTICALS LTD. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of VISTA PHARMACEUTICALS LTD.. The current rsi is 53.03. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
VISTA PHARMACEUTICALS LTD. Daily Relative Strength Index (RSI) ChartVISTA PHARMACEUTICALS LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of VISTA PHARMACEUTICALS LTD.. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the VISTA PHARMACEUTICALS LTD. price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
VISTA PHARMACEUTICALS LTD. Daily Stochastic Oscillator ChartVISTA PHARMACEUTICALS LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of VISTA PHARMACEUTICALS LTD.. The current cci is 63.59.

VISTA PHARMACEUTICALS LTD. Daily Commodity Channel Index (CCI) ChartVISTA PHARMACEUTICALS LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of VISTA PHARMACEUTICALS LTD.. The current cmo is 13.25.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
VISTA PHARMACEUTICALS LTD. Daily Chande Momentum Oscillator (CMO) ChartVISTA PHARMACEUTICALS LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of VISTA PHARMACEUTICALS LTD.. The current willr is -30.85585586.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that VISTA PHARMACEUTICALS LTD. is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
VISTA PHARMACEUTICALS LTD. Daily Williams %R ChartVISTA PHARMACEUTICALS LTD. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of VISTA PHARMACEUTICALS LTD..

VISTA PHARMACEUTICALS LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of VISTA PHARMACEUTICALS LTD.. The current atr is 0.94088442.

VISTA PHARMACEUTICALS LTD. Daily Average True Range (ATR) ChartVISTA PHARMACEUTICALS LTD. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of VISTA PHARMACEUTICALS LTD.. The current obv is 915,773.

VISTA PHARMACEUTICALS LTD. Daily On-Balance Volume (OBV) ChartVISTA PHARMACEUTICALS LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of VISTA PHARMACEUTICALS LTD.. The current mfi is 53.71.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
VISTA PHARMACEUTICALS LTD. Daily Money Flow Index (MFI) ChartVISTA PHARMACEUTICALS LTD. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for VISTA PHARMACEUTICALS LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-11-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-18ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-18MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

VISTA PHARMACEUTICALS LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of VISTA PHARMACEUTICALS LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5053.031
Ma 20Greater thanMa 5012.563
Ma 50Greater thanMa 10013.824
Ma 100Greater thanMa 20015.099
OpenGreater thanClose13.320
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of VISTA PHARMACEUTICALS LTD. with someone you think should read this too:
  • Are you bullish or bearish on VISTA PHARMACEUTICALS LTD.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about VISTA PHARMACEUTICALS LTD.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about VISTA PHARMACEUTICALS LTD.

I send you an email if I find something interesting about VISTA PHARMACEUTICALS LTD..


Comments

How you think about this?

Leave a comment

Stay informed about VISTA PHARMACEUTICALS LTD..

Receive notifications about VISTA PHARMACEUTICALS LTD. in your mailbox!